Patents by Inventor Robert Florentine

Robert Florentine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for extraction and purification of gangliosides
    Patent number: 9394558
    Abstract: Methods for purification and extraction of GM1 ganglioside from cells derived from sheep afflicted with GM1 gangliosidosis or from cells derived from human patients with GM1 gangliosidosis as stable and renewable sources of GM1.
    Type: Grant
    Filed: February 28, 2012
    Date of Patent: July 19, 2016
    Assignee: LZ Therapeutics, Inc.
    Inventors: Jay S. Schneider, Gerri Henwood, Robert Florentine, Christopher Barber
  • Ganglioside Transmucosal Formulations
    Publication number: 20160082026
    Abstract: A transmucosal formulation comprising a ganglioside and a mucosal absorption enhancer, as well as a method of treating or preventing Parkinson's disease in a human patient in need thereof comprising parenterally administering such a transmucosal formulation to said patient.
    Type: Application
    Filed: June 1, 2015
    Publication date: March 24, 2016
    Inventors: Jay S. Schneider, John J. Koleng, Robert Florentine, David W. Anderson
  • Ganglioside Transmucosal Formulations
    Publication number: 20150283158
    Abstract: A transmucosal formulation comprising a ganglioside and a mucosal absorption enhancer, as well as a method of treating or preventing Parkinson's disease in a human patient in need thereof comprising parenterally administering such a transmucosal formulation to said patient.
    Type: Application
    Filed: October 21, 2014
    Publication date: October 8, 2015
    Inventors: John J. Koleng, Robert Florentine, David W. Anderson, David W. Anderson
  • Treatment of Glaucoma and Other Retinopathies with Gangliosides
    Publication number: 20140309179
    Abstract: A method of treating or preventing a retinopathy such as glaucoma in a human patient in need thereof comprising administering one or more gangliosides to the patient.
    Type: Application
    Filed: April 17, 2014
    Publication date: October 16, 2014
    Applicant: LZ Therapeutics, Inc.
    Inventors: Jay S. Schneider, Gerri Henwood, Robert Florentine, David W. Anderson
  • Methods for Extraction and Purification of Gangliosides
    Publication number: 20120220763
    Abstract: Methods for purification and extraction of GM1 ganglioside from cells derived from sheep afflicted with GM1 gangliosidosis or from cells derived from human patients with GM1 gangliosidosis as stable and renewable sources of GM1.
    Type: Application
    Filed: February 28, 2012
    Publication date: August 30, 2012
    Inventors: Jay S. Schneider, Gerri Henwood, Robert Florentine, Christopher Barber
  • Ganglioside Transmucosal Formulations
    Publication number: 20120220544
    Abstract: A transmucosal formulation comprising a ganglioside and a mucosal absorption enhancer, as well as a method of treating or preventing Parkinson's disease in a human patient in need thereof comprising parenterally administering such a transmucosal formulation to said patient.
    Type: Application
    Filed: February 28, 2012
    Publication date: August 30, 2012
    Inventors: Jay S. Schneider, John J. Koleng, Robert Florentine, David W. Anderson
  • Treatment of Glaucoma and Other Retinopathies with Gangliosides
    Publication number: 20120220543
    Abstract: A method of treating or preventing a retinopathy such as glaucoma in a human patient in need thereof comprising administering one or more gangliosides to the patient.
    Type: Application
    Filed: February 28, 2012
    Publication date: August 30, 2012
    Inventors: Jay S. Schneider, Gerri Henwood, Robert Florentine, David W. Anderson